Assignee
EUBULUS BIOTHERAPEUTICS INC
CN·1 granted patent·4 pending applications·0 citations·filing 2019–2022
Top patents by PatentIndex Score
5 records- 0155US2025041306A1Targeted protease degradation (ted) platformEUBULUS BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0248US11998534B2GPX4 inhibitor in combination with anticancer agent for treating proliferative diseaseEUBULUS BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 4, 2024·0 cites·17 claims
- 0347US2024101546A1Heteroaryl-acetylenes, pharmaceutical compositions thereof, and their therapeutic applicationsEUBULUS BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0443US2023210999A1Targeted protease degradation (ted) platformEUBULUS BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0542US2021369853A1Targeted protease degradation platformEUBULUS BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →